These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33765771)

  • 1. Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.
    Onyema HN; Berger M; Musyanovych A; Bantz C; Maskos M; Freese C
    Biointerphases; 2021 Mar; 16(2):021004. PubMed ID: 33765771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
    Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
    Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs.
    Lin MH; Chung CY; Chen KT; Yeh JC; Lee TH; Lee MH; Lee IN; Huang WC; Yang JT
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum.
    Ndumiso M; Buchtová N; Husselmann L; Mohamed G; Klein A; Aucamp M; Canevet D; D'Souza S; Maphasa RE; Boury F; Dube A
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110816. PubMed ID: 31991290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.
    Lee CAA; Seo HS; Armien AG; Bates FS; Tolar J; Azarin SM
    Fluids Barriers CNS; 2018 Apr; 15(1):9. PubMed ID: 29615068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier.
    Cox A; Andreozzi P; Dal Magro R; Fiordaliso F; Corbelli A; Talamini L; Chinello C; Raimondo F; Magni F; Tringali M; Krol S; Jacob Silva P; Stellacci F; Masserini M; Re F
    ACS Nano; 2018 Jul; 12(7):7292-7300. PubMed ID: 29953205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of main influencing factors on the protein corona composition of PLGA and PLA nanoparticles.
    Spreen H; Behrens M; Mulac D; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2021 Jun; 163():212-222. PubMed ID: 33862242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons.
    Kuo YC; Tsai HC
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():445-457. PubMed ID: 30033276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype.
    Katt ME; Xu ZS; Gerecht S; Searson PC
    PLoS One; 2016; 11(4):e0152105. PubMed ID: 27070801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models.
    Hartl N; Gabold B; Adams F; Uhl P; Oerter S; Gätzner S; Metzger M; König AC; Hauck SM; Appelt-Menzel A; Mier W; Fricker G; Merkel OM
    J Control Release; 2023 Aug; 360():613-629. PubMed ID: 37437848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
    Kuo YC; Yu HW
    Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
    Kuo YC; Rajesh R
    Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.
    Sebak AA; Gomaa IEO; ElMeshad AN; Farag MH; Breitinger U; Breitinger HG; AbdelKader MH
    Int J Nanomedicine; 2020; 15():8845-8862. PubMed ID: 33204091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.
    Sobczynski DJ; Eniola-Adefeso O
    Acta Biomater; 2017 Jan; 48():186-194. PubMed ID: 27765678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
    Guarnieri D; Muscetti O; Netti PA
    Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.